Driehaus' Caldwell: Pandemic is not the big story for life-sciences stocks

Mike Calwell, manager of the Driehaus Life Sciences Fund, says that while investors are focused on the coronavirus pandemic and the companies poised to cash in on developing a vaccine, the next decade for life-sciences stocks should include wide-ranging personal health developments combatting things like heart disease and cancer that will still be among the nation's biggest killers long after the virus has passed. Caldwell suggests investors focus on the long-term and the more permanent opportunities, noting that some of the public funding to combat Covid-19 will contribute to advances in many other areas. Also on the show, author Steve Vernon talks about his latest book on the steps investors can take to avoid going broke in retirement, Matt Schulz of CompareCards.com discusses consumer savings amid the pandemic, and Tom Lydon of ETFTrends.com makes an IPO stock his 'ETF of the Week,' suggesting that investors may want to keep a permanent allocation to new and nascent stocks.